These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15880501)

  • 1. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
    Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
    Jie JZ; Wang JW; Qu JG; Hung T
    World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
    Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
    J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
    Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
    Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
    Lai RX; Zhang SN; Nakamura T; Yuan SZ
    Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.
    Maemondo M; Narumi K; Saijo Y; Usui K; Tahara M; Tazawa R; Hagiwara K; Matsumoto K; Nakamura T; Nukiwa T
    Mol Ther; 2002 Feb; 5(2):177-85. PubMed ID: 11829525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppression of peritoneal implantation by NK4 and its mechanisms].
    Atsuji K; Fujiwara H; Kubota T; Inada S; Takashima K; Yoshimura M; Ueda Y; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1777-9. PubMed ID: 15553712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based protein delivery system for the inhibition of the growth of pancreatic cancer: NK4 gene-transduced oral mucosal epithelial cell sheet.
    Manabe T; Mizumoto K; Nagai E; Matsumoto K; Nakamura T; Nukiwa T; Tanaka M; Matsuda T
    Clin Cancer Res; 2003 Aug; 9(8):3158-66. PubMed ID: 12912968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
    Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
    Egami T; Ohuchida K; Miyoshi K; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
    Cancer Sci; 2009 Apr; 100(4):722-9. PubMed ID: 19302285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
    Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S
    Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation.
    Kubota T; Taiyoh H; Matsumura A; Murayama Y; Ichikawa D; Okamoto K; Fujiwara H; Ikoma H; Nakanishi M; Kikuchi S; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Suzuki Y; Matsumoto K; Nakamura T; Otsuji E
    Int J Cancer; 2009 Dec; 125(12):2879-86. PubMed ID: 19588506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
    Lai RX; Yuan SZ; Nakamura T
    Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.